Publication Information

{'id': 'https://openalex.org/W2414378590', 'doi': None, 'title': 'The potential place of tenofovir in antiretroviral treatment regimens.', 'display_name': 'The potential place of tenofovir in antiretroviral treatment regimens.', 'publication_year': 2001, 'publication_date': '2001-12-01', 'ids': {'openalex': 'https://openalex.org/W2414378590', 'mag': '2414378590', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/11777298'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/11777298', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5110417535', 'display_name': 'Gazzard Bg', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210136304', 'display_name': 'Chelsea and Westminster Hospital', 'ror': 'https://ror.org/038zxea36', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2799869770', 'https://openalex.org/I4210136304']}], 'countries': ['GB'], 'is_corresponding': True, 'raw_author_name': 'Gazzard Bg', 'raw_affiliation_strings': ['Department of Genitourinary Medicine, Chelsea & Westminster Hospital, London, UK.'], 'affiliations': [{'raw_affiliation_string': 'Department of Genitourinary Medicine, Chelsea & Westminster Hospital, London, UK.', 'institution_ids': ['https://openalex.org/I4210136304']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5110417535'], 'corresponding_institution_ids': ['https://openalex.org/I4210136304'], 'apc_list': {'value': 2100, 'currency': 'USD', 'value_usd': 2100, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 0.389, 'has_fulltext': False, 'cited_by_count': 2, 'citation_normalized_percentile': {'value': 0.406918, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 66, 'max': 69}, 'biblio': {'volume': '55', 'issue': '10', 'first_page': '704', 'last_page': '9'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10526', 'display_name': 'HIV/AIDS drug development and treatment', 'score': 0.9896, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10526', 'display_name': 'HIV/AIDS drug development and treatment', 'score': 0.9896, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10082', 'display_name': 'HIV/AIDS Research and Interventions', 'score': 0.9523, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11725', 'display_name': 'Immunodeficiency and Autoimmune Disorders', 'score': 0.9021, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/tenofovir', 'display_name': 'Tenofovir', 'score': 0.8887203}, {'id': 'https://openalex.org/keywords/regimen', 'display_name': 'Regimen', 'score': 0.76475835}, {'id': 'https://openalex.org/keywords/reverse-transcriptase-inhibitor', 'display_name': 'Reverse-transcriptase inhibitor', 'score': 0.614516}, {'id': 'https://openalex.org/keywords/drug-holiday', 'display_name': 'Drug holiday', 'score': 0.5362733}, {'id': 'https://openalex.org/keywords/antiretroviral-treatment', 'display_name': 'Antiretroviral treatment', 'score': 0.42583722}, {'id': 'https://openalex.org/keywords/antiretroviral-agents', 'display_name': 'ANTIRETROVIRAL AGENTS', 'score': 0.41369528}], 'concepts': [{'id': 'https://openalex.org/C2779344132', 'wikidata': 'https://www.wikidata.org/wiki/Q155954', 'display_name': 'Tenofovir', 'level': 3, 'score': 0.8887203}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.88577545}, {'id': 'https://openalex.org/C2781413609', 'wikidata': 'https://www.wikidata.org/wiki/Q7308373', 'display_name': 'Regimen', 'level': 2, 'score': 0.76475835}, {'id': 'https://openalex.org/C2776543447', 'wikidata': 'https://www.wikidata.org/wiki/Q28734', 'display_name': 'Nucleoside', 'level': 2, 'score': 0.63090926}, {'id': 'https://openalex.org/C2777351918', 'wikidata': 'https://www.wikidata.org/wiki/Q421559', 'display_name': 'Reverse-transcriptase inhibitor', 'level': 5, 'score': 0.614516}, {'id': 'https://openalex.org/C2993143319', 'wikidata': 'https://www.wikidata.org/wiki/Q583050', 'display_name': 'Antiretroviral therapy', 'level': 4, 'score': 0.58953035}, {'id': 'https://openalex.org/C156719811', 'wikidata': 'https://www.wikidata.org/wiki/Q28774', 'display_name': 'Reverse transcriptase', 'level': 4, 'score': 0.57078606}, {'id': 'https://openalex.org/C2909970146', 'wikidata': 'https://www.wikidata.org/wiki/Q421559', 'display_name': 'Nucleoside Reverse Transcriptase Inhibitor', 'level': 5, 'score': 0.54084617}, {'id': 'https://openalex.org/C140206745', 'wikidata': 'https://www.wikidata.org/wiki/Q5308895', 'display_name': 'Drug holiday', 'level': 3, 'score': 0.5362733}, {'id': 'https://openalex.org/C3013748606', 'wikidata': 'https://www.wikidata.org/wiki/Q15787', 'display_name': 'Human immunodeficiency virus (HIV)', 'level': 2, 'score': 0.5216061}, {'id': 'https://openalex.org/C3018890749', 'wikidata': 'https://www.wikidata.org/wiki/Q204711', 'display_name': 'Food and drug administration', 'level': 2, 'score': 0.50829166}, {'id': 'https://openalex.org/C159047783', 'wikidata': 'https://www.wikidata.org/wiki/Q7215', 'display_name': 'Virology', 'level': 1, 'score': 0.48740938}, {'id': 'https://openalex.org/C2780035454', 'wikidata': 'https://www.wikidata.org/wiki/Q8386', 'display_name': 'Drug', 'level': 2, 'score': 0.48477358}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.4329578}, {'id': 'https://openalex.org/C3019165603', 'wikidata': 'https://www.wikidata.org/wiki/Q583050', 'display_name': 'Antiretroviral treatment', 'level': 5, 'score': 0.42583722}, {'id': 'https://openalex.org/C2909254382', 'wikidata': 'https://www.wikidata.org/wiki/Q583050', 'display_name': 'ANTIRETROVIRAL AGENTS', 'level': 5, 'score': 0.41369528}, {'id': 'https://openalex.org/C142462285', 'wikidata': 'https://www.wikidata.org/wiki/Q2528140', 'display_name': 'Viral load', 'level': 3, 'score': 0.39126262}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.34585595}, {'id': 'https://openalex.org/C67705224', 'wikidata': 'https://www.wikidata.org/wiki/Q11053', 'display_name': 'RNA', 'level': 3, 'score': 0.095153034}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.07454845}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.06426248}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000225', 'descriptor_name': 'Adenine', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': True}, {'descriptor_ui': 'D000225', 'descriptor_name': 'Adenine', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D019380', 'descriptor_name': 'Anti-HIV Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D015658', 'descriptor_name': 'HIV Infections', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D063065', 'descriptor_name': 'Organophosphonates', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D009943', 'descriptor_name': 'Organophosphorus Compounds', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D018894', 'descriptor_name': 'Reverse Transcriptase Inhibitors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000225', 'descriptor_name': 'Adenine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019380', 'descriptor_name': 'Anti-HIV Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D024882', 'descriptor_name': 'Drug Resistance, Viral', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006678', 'descriptor_name': 'HIV', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D006678', 'descriptor_name': 'HIV', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015658', 'descriptor_name': 'HIV Infections', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009943', 'descriptor_name': 'Organophosphorus Compounds', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018894', 'descriptor_name': 'Reverse Transcriptase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000068698', 'descriptor_name': 'Tenofovir', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/11777298', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.82, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W2903951766', 'https://openalex.org/W2414378590', 'https://openalex.org/W2399282214', 'https://openalex.org/W2228518889', 'https://openalex.org/W2074810364', 'https://openalex.org/W2067802590', 'https://openalex.org/W2059960892', 'https://openalex.org/W2031899830', 'https://openalex.org/W1974265555', 'https://openalex.org/W1964377508'], 'abstract_inverted_index': {'Advice': [0], 'from': [1], 'the': [2, 8, 35, 116], 'Food': [3], '&': [4], 'Drug': [5], 'Administration': [6], 'and': [7], 'European': [9], 'Medicines': [10], 'Commission': [11], 'indicates': [12], 'that': [13, 42], 'tenofovir': [14], 'is': [15, 38], 'likely': [16], 'to': [17, 48, 65, 70, 94], 'be': [18, 71, 108], 'licensed': [19], 'shortly': [20], 'for': [21], 'use': [22, 63], 'in': [23, 44, 102], 'patients': [24], 'failing': [25], 'antiretroviral': [26], 'therapy': [27], 'as': [28], 'part': [29, 109], 'of': [30, 110, 118], 'a': [31, 39, 45, 111], 'regimen': [32], 'constructed': [33], 'by': [34, 51], 'clinician.': [36], 'Tenofovir': [37], 'nucleotide': [40], '(NtRTI)': [41], 'acts': [43], 'similar': [46, 56], 'way': [47], 'nucleoside': [49, 96], 'analogues': [50], 'inhibiting': [52], 'reverse': [53], 'transcriptase,': [54], 'producing': [55], 'HIV': [57, 86], 'plasma': [58], 'viral': [59], 'load': [60], 'fall.': [61], 'In': [62], 'up': [64], '48': [66], 'weeks': [67], 'it': [68, 81, 106], 'appears': [69], 'safe': [72], 'without': [73], 'evident': [74], 'toxicity.': [75], 'It': [76], 'has': [77, 82], 'particular': [78], 'value': [79], 'because': [80], 'activity': [83], 'against': [84], 'many': [85], 'viruses': [87], 'with': [88], 'mutations': [89], 'which': [90], 'render': [91], 'them': [92], 'insensitive': [93], 'other': [95], 'analogues.': [97], 'Its': [98], 'eventual': [99], 'optimal': [100], 'role': [101], 'treatment,': [103], 'particularly': [104], 'whether': [105], 'should': [107], 'first': [112], 'line': [113], 'regimen,': [114], 'awaits': [115], 'outcome': [117], 'further': [119], 'studies.': [120]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2414378590', 'counts_by_year': [], 'updated_date': '2025-01-15T18:23:59.561219', 'created_date': '2016-06-24'}